Steward Partners Investment Advisory’s Amicus Therapeutics FOLD Stock Holding History

Steward Partners Investment Advisory’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$14.5K	–	4741
2026 Q1	$14.5K	Hold	1,000	–	–	﹤0.01%	3386
2025 Q4	$14.2K	Hold	1,000	–	–	﹤0.01%	3289
2025 Q3	$7.88K	Buy	+1,000	New	+$7.12K	﹤0.01%	3502

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Steward Partners Investment Advisory's FOLD Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,000 shares — an estimated $14.5K sold.

Steward Partners Investment Advisory first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $14.5K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 1,000 Amicus Therapeutics shares in Q2 2026, an estimated $14.5K.
Steward Partners Investment Advisory first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
Steward Partners Investment Advisory's Amicus Therapeutics position peaked at $14.5K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.